Omeros Corp
OMERNasdaqCIK 1285819HealthcareFiscal year ends Dec 31
Reports and events: 273 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1316:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001552781-26-000441 |
| 2026-08-1216:12 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027318 |
| 2026-08-1216:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027313 |
| 2026-07-2017:05 ET | 8-K | 8.01 Other events | 0001437749-26-023886 |
| 2026-07-0608:30 ET | 8-K | 8.01 Other events | 0001552781-26-000377 |
| 2026-06-2506:02 ET | 8-K | 5.07 Shareholder vote results | 0001437749-26-021617 |
| 2026-06-1807:52 ET | 8-K | 8.01 Other events | 0001437749-26-021040 |
| 2026-05-1316:07 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-016720 |
| 2026-05-1316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016718 |
| 2026-04-3008:00 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001552781-26-000281 |
| 2026-03-3116:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-010636 |
| 2026-03-3116:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-010634 |
| 2026-01-0717:15 ET | 8-K | 2.02 Results of operations | 0001437749-26-000820 |
| 2025-12-2906:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038758 |
| 2025-12-0108:30 ET | 8-K | 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-036507 |
| 2025-11-1316:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034826 |
| 2025-11-1316:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034824 |
| 2025-10-1508:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-030968 |
| 2025-08-1416:09 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-026933 |
| 2025-08-1416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-026931 |
| 2025-07-2508:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-070554 |
| 2025-07-0216:07 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-021959 |
| 2025-05-3016:37 ET | DEF 14A | Proxy statementPeriod 2025-06-27 | 0001140361-25-020948 |
| 2025-05-1616:29 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001437749-25-017426 |
| 2025-05-1516:32 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-017213 |
| 2025-05-1516:31 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-017211 |
| 2025-05-0617:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-014815 |
| 2025-04-3017:08 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001437749-25-013902 |
| 2025-03-3116:28 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-010216 |
| 2025-03-3116:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-010211 |
| 2025-02-2009:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-004505 |
| 2025-01-1609:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-001245 |
| 2024-12-1909:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-037898 |
| 2024-11-1316:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034903 |
| 2024-11-1316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-034900 |
| 2024-08-0716:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-025181 |
| 2024-08-0716:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-025179 |
| 2024-06-1216:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001437749-24-020102 |
| 2024-06-0309:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-018964 |
| 2024-05-1516:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-017047 |
| 2024-05-1516:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-017044 |
| 2024-04-2917:23 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0001437749-24-013762 |
| 2024-04-0117:20 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-010416 |
| 2024-04-0116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-010359 |
| 2024-02-0708:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001437749-24-003287 |
| 2023-11-0916:06 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-031250 |
| 2023-11-0916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-031249 |
| 2023-10-1616:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-028296 |
| 2023-08-0908:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-014095 |
| 2023-08-0908:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-014088 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.